L-shaped association of serum α-Klotho and frailty among the middle-aged and older adults: results from NHANES 2007-2016.
Frailty
Middle-aged and older adults
NHANES
α-Klotho
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
03 11 2023
03 11 2023
Historique:
received:
03
04
2023
accepted:
16
09
2023
medline:
6
11
2023
pubmed:
4
11
2023
entrez:
4
11
2023
Statut:
epublish
Résumé
Frailty is common and not limited to older age group. Serum α-Klotho works as a biomarker of anti-aging effect. However, there is limited research about the relationship between them in middle-aged and older people and controversy still exists. Based on data from National Health and Nutrition Examination Survey (NHANES) 2007-2016, we constructed weighted logistic regression models and conducted sensitivity tests to investigate the correlation between frailty and α-Klotho among people aged 40 to 79. And then their relationship was visualized by Restricted Cubic Spline (RCS). Finally, the stratified analyses and interaction tests of covariables was presented in the forest plot. A total of 7052 individuals were involved in this study, with mean age of 62.76 ± 0.18 years and females accounting for 51.05%. 2554 of them were in "frailty". After adjustment for relevant covariables, weighted logistic regression models showed that the odds ratio and 95% confidence interval [ORs (95%CI)] of correlation between frailty and Natural Logarithm(ln)-transformed α- Klotho[ln(α-Klotho)] was 0.63 (0.50, 0.79); we then performed a sensitivity analysis and found that the results remained stable. In model 3, individuals in quartiles 2, 3, and 4 showed statistical differences compared with the lowest ln(α-Klotho) quartiles, ORs (95% CI) were 0.74 (0.59, 0.93), 0.72 (0.57, 0.91), 0.71 (0.57, 0.87), respectively. Subsequently, non-linear associations were exhibited by RCS (p<0.001). The turning point for α-Klotho and ln(α-Klotho) were 785.7(pg/ml) and 6.67, respectively. Finally, analysis of the relationship between different levels of ln(α-Klotho) and frailty in different populations revealed differences between groups. The results of the interaction test showed that no other covariables had significant interaction with serum α-Klotho in our study. The L-shaped and negative correlation was found between α-Klotho and frailty among people aged 40 to 79 in the NHANES from 2007 to 2016.
Sections du résumé
BACKGROUND
Frailty is common and not limited to older age group. Serum α-Klotho works as a biomarker of anti-aging effect. However, there is limited research about the relationship between them in middle-aged and older people and controversy still exists.
METHODS
Based on data from National Health and Nutrition Examination Survey (NHANES) 2007-2016, we constructed weighted logistic regression models and conducted sensitivity tests to investigate the correlation between frailty and α-Klotho among people aged 40 to 79. And then their relationship was visualized by Restricted Cubic Spline (RCS). Finally, the stratified analyses and interaction tests of covariables was presented in the forest plot.
RESULTS
A total of 7052 individuals were involved in this study, with mean age of 62.76 ± 0.18 years and females accounting for 51.05%. 2554 of them were in "frailty". After adjustment for relevant covariables, weighted logistic regression models showed that the odds ratio and 95% confidence interval [ORs (95%CI)] of correlation between frailty and Natural Logarithm(ln)-transformed α- Klotho[ln(α-Klotho)] was 0.63 (0.50, 0.79); we then performed a sensitivity analysis and found that the results remained stable. In model 3, individuals in quartiles 2, 3, and 4 showed statistical differences compared with the lowest ln(α-Klotho) quartiles, ORs (95% CI) were 0.74 (0.59, 0.93), 0.72 (0.57, 0.91), 0.71 (0.57, 0.87), respectively. Subsequently, non-linear associations were exhibited by RCS (p<0.001). The turning point for α-Klotho and ln(α-Klotho) were 785.7(pg/ml) and 6.67, respectively. Finally, analysis of the relationship between different levels of ln(α-Klotho) and frailty in different populations revealed differences between groups. The results of the interaction test showed that no other covariables had significant interaction with serum α-Klotho in our study.
CONCLUSION
The L-shaped and negative correlation was found between α-Klotho and frailty among people aged 40 to 79 in the NHANES from 2007 to 2016.
Identifiants
pubmed: 37924002
doi: 10.1186/s12877-023-04324-z
pii: 10.1186/s12877-023-04324-z
pmc: PMC10623765
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
716Informations de copyright
© 2023. The Author(s).
Références
J Gerontol A Biol Sci Med Sci. 2011 Jul;66(7):794-800
pubmed: 21474560
Arch Gerontol Geriatr. 2015 May-Jun;60(3):464-70
pubmed: 25697060
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Environ Int. 2019 Oct;131:105057
pubmed: 31398592
Exp Gerontol. 2021 Oct 15;154:111518
pubmed: 34407459
Nat Aging. 2023 Aug;3(8):931-937
pubmed: 37400721
Vitam Horm. 2016;101:119-50
pubmed: 27125740
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Kidney Int. 2010 Dec;78(12):1240-51
pubmed: 20861825
Nature. 1997 Nov 6;390(6655):45-51
pubmed: 9363890
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):452-456
pubmed: 34628493
J Clin Oncol. 2017 Jan 10;35(2):149-156
pubmed: 27893337
J Am Geriatr Soc. 2006 Jun;54(6):975-9
pubmed: 16776795
Age Ageing. 2018 Mar 1;47(2):193-200
pubmed: 29040347
Arch Gerontol Geriatr. 2020 Aug 8;91:104225
pubmed: 32905907
Lung. 2017 Feb;195(1):53-57
pubmed: 27752830
Age (Dordr). 2016 Feb;38(1):1
pubmed: 26695510
Endocr Rev. 2015 Apr;36(2):174-93
pubmed: 25695404
Intensive Care Med. 2017 Aug;43(8):1105-1122
pubmed: 28676896
BMC Cardiovasc Disord. 2022 Oct 11;22(1):442
pubmed: 36221064
Front Public Health. 2022 Oct 06;10:995314
pubmed: 36276390
Pflugers Arch. 2010 Jan;459(2):333-43
pubmed: 19730882
J Gerontol A Biol Sci Med Sci. 2019 Jun 18;74(7):1052-1057
pubmed: 29053774
Age Ageing. 2015 Nov;44(6):967-72
pubmed: 26504118
Clin Geriatr Med. 2018 Nov;34(4):667-675
pubmed: 30336994
Front Endocrinol (Lausanne). 2022 Nov 09;13:1005553
pubmed: 36440221
Lancet. 2019 Oct 12;394(10206):1298
pubmed: 31609212
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Lancet. 2019 Oct 12;394(10206):1365-1375
pubmed: 31609228
BMC Geriatr. 2021 Sep 17;21(1):499
pubmed: 34535074
Science. 2007 Aug 10;317(5839):803-6
pubmed: 17690294
J Am Geriatr Soc. 2010 Apr;58(4):681-7
pubmed: 20345864
Eur J Intern Med. 2018 Oct;56:49-52
pubmed: 29526651
Redox Biol. 2017 Oct;13:94-162
pubmed: 28577489
Mol Aspects Med. 2016 Aug;50:1-32
pubmed: 27370407
Biochem Biophys Res Commun. 2010 Jul 30;398(3):513-8
pubmed: 20599764
J Am Med Dir Assoc. 2023 Aug;24(8):1173-1178.e2
pubmed: 37001558
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
J Am Soc Nephrol. 2017 Jun;28(6):1859-1866
pubmed: 28104822
J Clin Invest. 2012 Aug;122(8):2749-55
pubmed: 22850885
J Am Med Dir Assoc. 2021 Mar;22(3):559-563.e2
pubmed: 32859517
Biochem Biophys Res Commun. 1998 Jan 26;242(3):626-30
pubmed: 9464267
Clin Geriatr Med. 2018 Feb;34(1):25-38
pubmed: 29129215
Age Ageing. 2021 Jan 8;50(1):161-168
pubmed: 32808971
Cell Rep. 2017 Aug 8;20(6):1360-1371
pubmed: 28793260
Lancet. 2019 Oct 12;394(10206):1376-1386
pubmed: 31609229